| Financial Year |
March 31 2023 |
| Monetary Funds |
248,525,268.02 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
812,310.89 |
| Other Receivables |
132,666.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
140,404,795.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,348,877.20 |
| Total Current Assets |
396,223,917.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
278,611,480.00 |
| Under-construction Projects |
24,984,169.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,096,954.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
88,741.40 |
| Deferred Income Tax Assets |
10,818,154.32 |
| Other Non-Current Assets |
800,100.00 |
| Sub-Total of Non-Current Assets |
327,016,795.31 |
| Total Assets |
723,240,713.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
22,952,222.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,738,468.15 |
| Taxes Payable |
156,539.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,504,349.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
13,971,799.69 |
| Sub-Total of Current Liabilities |
71,499,850.31 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
31,960,974.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,490,672.19 |
| Total Liabilities |
117,990,522.50 |
| Paid-In Capital(Or Share Stock) |
129,639,500.00 |
| Capital Surplus |
258,946,224.12 |
| Surplus Reserve |
59,614,799.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
112,623,214.82 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
605,250,190.55 |
| Owner's Equity（Stockholder's Equity） |
605,250,190.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
723,240,713.05 |
